EFTA02715650Set 11
2015-06-253p2,323w
drug poses apeutic efficacy and risk. Patients 20150519/103516/BILLS-1146ih.pdf).
2. Kesselheim AS, Tan YT. Avom J. The roles
"minimal risk." and physicians would not benefit of academia, rare diseases. and repurposing
https://www.justice.gov/epstein/files/DataSet%2011/EFTA02715650.pdf